From Medscape Dermatology

Coverage from the

European Academy of Dermatology and Venereology (EADV) 2024 Congress

September 25 - 28, 2024; Amsterdam, The Netherlands

September 25 - 28, 2024 Amsterdam, The Netherlands

Conference News

EADV 2024 Bimekizumab Offers Durable and Consistent Benefits in HS
Medscape Medical News, November 4, 2024
EADV 2024 Nemolizumab Reassures in Long-Term Atopic Dermatitis Study
Medscape Medical News, October 21, 2024
EADV 2024 Ruxolitinib Cream Shows Promise in Treating Lichen Planus
Medscape Medical News, October 18, 2024
EADV 2024 No Excess MACE Risk for JAKis in Atopic Dermatitis Analysis
Medscape Medical News, October 18, 2024
EADV 2024 Facial Melasma Improves With New Cosmeceutical
Medscape Medical News, October 17, 2024
EADV 2024 Children With Severe AD Catch Up on Growth With Dupilumab
Medscape Medical News, October 16, 2024
EADV 2024 Late Dupilumab Responders Have Unique Molecular Profile
Medscape Medical News, October 9, 2024
EADV 2024 Phase 3 Izokibep Study in HS Produces Promising Results
Medscape Medical News, October 8, 2024
EADV 2024 Hand Eczema: Delgocitinib Takes on Established Treatments
Medscape Medical News, October 8, 2024

EADV 2024 New Drug Class for Prurigo Nodularis Moving Forward
Medscape Medical News, October 7, 2024
EADV 2024 Molecular Effects of Investigational AD Treatment Described
Medscape Medical News, October 4, 2024
EADV 2024 Topical JAK inhibitor Provides Sustained Control of HS
Medscape Medical News, October 3, 2024
EADV 2024 Study Supports Use of Home-Based Phototherapy for Psoriasis
Medscape Medical News, October 3, 2024
EADV 2024 HS Symptoms Eased by Semaglutide-Aided Weight Loss
Medscape Medical News, October 2, 2024
EADV 2024 Topical JAKi Shows Promise for Frontal Fibrosing Alopecia
Medscape Medical News, October 2, 2024
EADV 2024 Durable Responses Seen With Barzolvolimab in CSU Trial
Medscape Medical News, October 1, 2024
EADV 2024 Atopic Dermatitis Control on Biologic Persists Over 3 Years
Medscape Medical News, September 30, 2024
EADV 2024 Eczema Starting in Childhood Adds Burden in Adulthood
Medscape Medical News, September 27, 2024

Medscape Dermatology©

Popular News from EADV 2023

At 52 Weeks, Hair Growth Still Climbing on Deuruxolitinib With response curves still climbing at follow-up to date, the results are 'truly, truly remarkable.'
Medscape Medical News, Nov 28, 2023
Vitiligo: 'Impressive' Results for Povorcitinib, Baricitinib Substantial facial and total body repigmentation in patients with nonsegmental vitiligo was achieved in separate trials of povorcitinib and baricitinib plus phototherapy.
Medscape Medical News, Nov 08, 2023
Topical Ivermectin Study Sheds Light on Dysbiosis in Rosacea Study findings show that ivermectin reduces the density of Demodex folliculorum in rosacea lesions, but the skin microbiome takes time to recover.
Medscape Medical News, Nov 03, 2023

Previous Coverage

Related Resources

All material on this website is protected by copyright, Copyright © 1994-2025 by WebMD LLC. This website also contains material copyrighted by 3rd parties.